BELITE BIO INC - ADR (BLTE:NASDAQ)
$138.18 1.33 (0.9719%)
Analysed BELITE BIO INC - ADR (BLTE:NASDAQ) News Sources
Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026)
15-05-2026
yahoo.com
Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland
18-05-2026
yahoo.com
Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
20-05-2026
yahoo.com
Belite Bio shares rise after first-quarter earnings outperform expectations (BLTE)
20-05-2026
advfn.com
Belite Bio (BLTE) Q1 2026 Earnings Transcript
20-05-2026
fool.com
Belite Bio Q1 Earnings Call Highlights
20-05-2026
marketbeat.com
Belite Bio Inc (BLTE) Q1 2026 Earnings Call Highlights: Strategic Advancements Amid Rising Expenses
21-05-2026
yahoo.com
Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
02-06-2026
yahoo.com
We're Not Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn
12-06-2026
yahoo.com
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
13-06-2026
yahoo.com
What is the current price of BELITE BIO INC - ADR (BLTE:NASDAQ)?
The current price of BELITE BIO INC - ADR (BLTE:NASDAQ) is $138.18.
BELITE BIO INC - ADR (BLTE:NASDAQ) absolute price change since previous trading day?
The absolute price change of BELITE BIO INC - ADR (BLTE:NASDAQ) since the previous trading day is $1.33.
BELITE BIO INC - ADR (BLTE:NASDAQ) percentage price change since previous trading day?
The percentage price change of BELITE BIO INC - ADR (BLTE:NASDAQ) since the previous trading day is 0.9719%.
What is the most recent average sentiment score for BELITE BIO INC - ADR (BLTE:NASDAQ)?
The most recent average sentiment score for BELITE BIO INC - ADR (BLTE:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for BELITE BIO INC - ADR (BLTE:NASDAQ)?
The most recent sentiment for BELITE BIO INC - ADR (BLTE:NASDAQ) is .
SEC-8K** Filing Available For BELITE BIO INC - ADR (BLTE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.